Beschreibung
Mendelian randomization estimates illustrate the association between genetically predicted 25-hydroxyvitamin D levels and autoimmune disease risk. Genetic instruments derived from genome-wide association studies serve as proxies for long-term vitamin D exposure.
Figure 3
Forest PlotSource Paper
Associations between vitamin D and autoimmune diseases: Mendelian randomization analysis.Cite This Figure
![Figure 3: Mendelian randomization estimates illustrate the association between genetically predicted 25-hydroxyvitamin D levels and autoimmune disease risk. Genetic instruments derived from genome-wide association studies serve as proxies for long-term vitamin D exposure.]() > Source: Sizheng Steven Zhao et al. "Associations between vitamin D and autoimmune diseases: Mendelian randomization ." *Seminars in arthritis and rheumatism*, 2023. PMID: [37437450](https://pubmed.ncbi.nlm.nih.gov/37437450/)
<figure> <img src="" alt="Mendelian randomization estimates illustrate the association between genetically predicted 25-hydroxyvitamin D levels and autoimmune disease risk. Genetic instruments derived from genome-wide association studies serve as proxies for long-term vitamin D exposure." /> <figcaption>Figure 3. Mendelian randomization estimates illustrate the association between genetically predicted 25-hydroxyvitamin D levels and autoimmune disease risk. Genetic instruments derived from genome-wide association studies serve as proxies for long-term vitamin D exposure.<br> Source: Sizheng Steven Zhao et al. "Associations between vitamin D and autoimmune diseases: Mendelian randomization ." <em>Seminars in arthritis and rheumatism</em>, 2023. PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/37437450/">37437450</a></figcaption> </figure>